Medical Oncology · 2016 · 16 citations · 28 references
MedicineHematologyOncologyCancer ImmunologyHematologic OncologyNeoplasiaBone Marrow EvaluationHematologic MalignanciesHematologic Malignancy TherapyHematopoietic NeoplasmsMultiple MyelomaPlasma Cell NeoplasmsMultiple Myeloma TherapyMyeloid NeoplasmsMyeloma PathogenesisPlasma Cell BiologyPlasma Cell Bone Marrow Microenvironment
28
A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma
Paul G. Richardson, Bart Barlogie, James R. Berenson et al. · New England Journal of Medicine · 2003 · 2.6K citations · Full text
Bortezomib or High-Dose Dexamethasone for Relapsed Multiple Myeloma
Paul G. Richardson, Pieter Sonneveld, Michael W. Schuster et al. · New England Journal of Medicine · 2005 · 2.5K citations · Full text
Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells
Esther A. Obeng, Louise Carlson, Delia Gutman et al. · Blood · 2006 · 1.1K citations · Full text